Bionaut Labs

Precision-targeted Medicine Modality for CNS Disorders

Health Tech & Life Sciences
Non Active, Jun 2026 ceased to operate

Company Overview

Snapshot

Founded in January 2016 by Aviad Maizels, Michael Shpigelmacher, and Alexander Shpunt, Bionaut Labs operates with 11–50 employees. The company has raised a total of $69.2M across 3 funding rounds from 15 investors. In February 2024, the company secured an extension round with participation from OurCrowd and Upfront Ventures, signaling continued investor confidence in its micro-robot technology.

Business overview

Bionaut Labs is a biotechnology startup developing a precision medicine treatment modality for central nervous system (CNS) disorders. The company utilizes remote-controlled microscale robots, known as Bionauts, to deliver biologics, nucleic acids, or small molecule therapies directly to targeted CNS disease areas. This approach aims to enhance efficacy and safety compared to traditional treatment methods. Bionaut Labs is initially focusing on indications such as gliomas and Huntington's disease, leveraging custom-engineered therapeutic micro-robots that can precisely target payloads within the body.

Strategic signal

Bionaut Labs secured an extension funding round in February 2024, indicating ongoing investor support as the company prepares for clinical trials of its micro-robot technology. This development suggests a critical step forward in validating the therapeutic potential of their precision drug delivery system for CNS disorders, positioning the company for potential advancements in addressing challenging neurological conditions.

Company Intelligence Q&A

What is the primary focus of Bionaut Labs' technology?
Bionaut Labs focuses on treating central nervous system (CNS) disorders using remote-controlled microscale robots, called Bionauts, to deliver therapies precisely to targeted disease areas.
When did Bionaut Labs raise its most recent funding round?
Bionaut Labs raised an extension funding round in February 2024, with participation from investors including OurCrowd and Upfront Ventures.
Which investors participated in the November 2022 funding round?
In November 2022, Khosla Ventures led a funding round for.
When did Bionaut Labs exit stealth mode?
Bionaut Labs exited stealth mode in March 2021, announcing funding from investors including Khosla Ventures.
What is the current operational status of Bionaut Labs?
Bionaut Labs is currently non-active, having ceased to operate in June 2026.

External links